E-LIB Suche - Ergebnisse für: Efebera, Yvonne A

1

Impact of Visceral Obesity on Clinical Outcome and Quality ..:

Malek, Ehsan ; Kort, Jeries ; Metheny, Leland...
Transplantation and Cellular Therapy. , 2024

2

Post hoc analysis of daratumumab plus lenalidomide, bortezo..:

Nooka, Ajay K. ; Kaufman, Jonathan L. ; Rodriguez, Cesar...
British Journal of Haematology. 204 (2024) 6 - p. 2227-2232 , 2024

Link: https://doi.org/10.1111/..

3

P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DAR..:

Miguel, Enrique Maria Ocio San ; Efebera, Yvonne A. ; Hájek, Roman...
HemaSphere. 7 (2023) S3 - p. e2842627 , 2023

Link: https://doi.org/10.1097/..

4

Editorial: Autologous and Allogeneic Stem Cell Transplant i..:

Sharma, Nidhi ; Efebera, Yvonne A.
Cancers. 15 (2023) 5 - p. 1354 , 2023

Link: https://doi.org/10.3390/..

5

P-302 Anchor (OP-104): melflufen plus dexamethasone and dar..:

Ocio, Enrique ; Efebera, Yvonne ; Hájek, Roman...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S204 , 2023

Link: https://doi.org/10.1016/..

6

Outcomes associated with allogeneic hematopoietic stem cell..:

Faisal, Muhammad Salman ; Hanel, Walter ; Voorhees, Timothy...
Cancer Medicine. 12 (2023) 7 - p. 8228-8237 , 2023

Link: https://doi.org/10.1002/..

7

Impact of Visceral Obesity on Clinical Outcome and Quality ..:

Malek, Ehsan ; Kort, Jeries ; Metheny, Leland...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S399-S400 , 2023

Link: https://doi.org/10.1016/..

8

Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion ..:

Chung, David J. ; Shah, Nina ; Wu, Juan...
Clinical Cancer Research. 29 (2023) 23 - p. 4784-4796 , 2023

Link: https://doi.org/10.1158/..

9

Monitoring, prophylaxis, and treatment of infections in pat..:

Raje, Noopur ; Anderson, Kenneth ; Einsele, Hermann...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

Comparison of Patient Outcomes With Two Different Formulati..:

Khan, Abdullah M. ; Yucebay, Filiz ; Zhao, Qiuhong...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 2 - p. e85-e96 , 2023

Link: https://doi.org/10.1016/..

11

Lenalidomide in the treatment of anti‐myelin‐associated gly..:

Stino, Amro M. ; Bumma, Naresh ; Smith, Rachel...
European Journal of Neurology. 31 (2023) 3 - p. , 2023

Link: https://doi.org/10.1111/..

12

Real-world multiple myeloma risk factors and outcomes by no..:

Buck, Tondre ; Hartley-Brown, Monique A. ; Efebera, Yvonne A....
Haematologica. , 2023

Link: https://doi.org/10.3324/..

13

A Multicenter Phase II, Double-Blind, Placebo-Controlled Tr..:

Bashir, Qaiser ; Nishihori, Taiga ; Pasquini, Marcelo C....
Transplantation and Cellular Therapy. 29 (2023) 6 - p. 358.e1-358.e7 , 2023

Link: https://doi.org/10.1016/..

14

ANCHOR: melflufen plus dexamethasone and daratumumab or bor..:

Ocio, Enrique M. ; Efebera, Yvonne A. ; Hájek, Roman...
Haematologica. 109 (2023) 3 - p. 867-876 , 2023

Link: https://doi.org/10.3324/..

15

P-020 Dendritic cell/myeloma fusion vaccine with lenalidomi..:

Karagkouni, Dimitra ; Cheloni, Giulia ; Torres, Daniela...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S43-S44 , 2023

Link: https://doi.org/10.1016/..